Kyntra Bio (KYNB) Change in Account Payables (2014 - 2026)

Kyntra Bio has reported Change in Account Payables for 13 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Change in Account Payables rose 105.45% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 146.17% YoY) and the FY2025 annual result came in at -$27.7 million, down 290.56% from the prior year.
• Change in Account Payables improved to $1.3 million in Q1 2026 per KYNB's latest filing, from -$1.3 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $40.5 million in Q1 2023 and troughed at -$61.3 million in Q2 2023.
• A 5-year average of -$1.3 million and a median of -$728000.0 in 2024 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables tumbled 9029.41% in 2022, then surged 1693.48% in 2024.
• Over 5 years, Change in Account Payables stood at $11.0 million in 2022, then slumped by 113.21% to -$1.5 million in 2023, then soared by 1693.48% to $23.2 million in 2024, then sank by 105.81% to -$1.3 million in 2025, then jumped by 200.07% to $1.3 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $1.3 million, -$1.3 million, and -$4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.